EHMT1 抗体
(2 references)Quick Overview for EHMT1 抗体 (ABIN966204)
抗原
See all EHMT1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
特异性
- Ni-NTA purified truncated recombinant GLP expressed in E. Coli strain BL21 (DE3)
-
纯化方法
- Antibodies are purified by protein A affinity chromatography
-
亚型
- IgG1
-
-
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) (AA 1-100) antibody
EHMT1 适用: 人 WB, ELISA, IF 宿主: 小鼠 Monoclonal 3G1 unconjugated
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) antibodyEHMT1 适用: 人, 小鼠, 大鼠 WB, IF (p), IHC (p) 宿主: 小鼠 Monoclonal 1G9 unconjugated
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) antibodyEHMT1 适用: 人, 小鼠, 大鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) antibodyEHMT1 适用: 人 ELISA 宿主: 小鼠 Monoclonal 1B7B4 unconjugated
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) (AA 1-100) antibodyEHMT1 适用: 人 WB, ELISA 宿主: 小鼠 Polyclonal unconjugated
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) (Internal Region) antibodyEHMT1 适用: 人, 小鼠 WB, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) (AA 1-260) antibodyEHMT1 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Western Blot: Dilution 1: 200- 1: 1,000
ELISA: Propose dilution 1: 10,000
Determining optimal working dilutions by titration test. -
限制
- 仅限研究用
-
-
-
储存条件
- -20 °C
-
-
-
: "Inhibition of glucagon secretion." in: Advances in pharmacology (San Diego, Calif.), Vol. 52, pp. 151-71, (2006) (PubMed).
: "Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus." in: The international journal of biochemistry & cell biology, Vol. 38, Issue 5-6, pp. 845-59, (2006) (PubMed).
-
: "Inhibition of glucagon secretion." in: Advances in pharmacology (San Diego, Calif.), Vol. 52, pp. 151-71, (2006) (PubMed).
-
- EHMT1 (Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1))
-
别名
- GLP
-
背景
- Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from enteroendocrine L cells in response to ingested nutrients. The closely related peptides glucagon-like peptide (GLP-1) and glucagon have opposing effects on blood glucose. GLP-1 induces glucose-dependent insulin secretion in the pancreas, while glucagon stimulates gluconeogenesis and glycogenolysis in the liver. Glucagon is processed from a large precursor, proglucagon, in a tissue-specific manner in pancreatic alpha-cells. The identification of a hybrid peptide acting as both a GLP-1 agonist and a glucagon antagonist would provide a novel approach for the treatment of type 2 diabetes.
-
基因ID
- 79813
抗原
-
